Calcium looping example, adding Ca-looping to all coal-fired plants in the UK would generate enough waste for 33 Mtonnes/yr of cement production, whereas current cement production in the UK is only 12.5 Mtonnes/yr. Hence, if the technology is applied on a large scale, the purge rate of CaO should be optimized to minimize waste. To fully gauge the viability of calcium looping as a capture process, it is necessary to consider the political, environmental, and health effects of the process as well. Though many recent scientific reports (e.g.: the seven-wedge stabilization plan by Pacala and Socolow) convey an urgent need to deploy
Calcium channel opener Calcium channel opener A calcium channel opener is a type of drug which facilitates ion transmission through calcium channels. An example is Bay K8644, which is an analogue of nifedipine that specifically and directly activates L-type voltage-dependent calcium channels. In contrast to Bay K8644, which is not for clinical use, Ambroxol is a frequently used mucolytic drug that triggers lysosomal secretion by mobilizing calcium from acidic calcium stores. This effect does most likely not occur by a direct interaction between the drug and a lysosomal calcium channel, but indirectly by neutralizing the acidic pH within lysosomes. Calcium permeable ion channels